DRKS00033000招募中不适用
OUTCOME AND TOXICITY OF TOTAL NEOADJUVANT THERAPY IN RECTAL CANCER - TNTox
niversitätsklinikum Jena0 个研究点目标入组 350 人开始时间: 2023年11月7日最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 招募中
- 发起方
- 入组人数
- 350
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 18 Years 至 one（—）
- 性别
- All
入选标准
- •Patients with locally advanced rectal cancer (LARC), UICC stage II/III who underwent total neoadjuvant therapy (TNT)
- •adequately measured tumor response (histologically and / or radiologically plus endoscopically)
- •available follow-up data (min. 6 months)
排除标准
- •Enrollment in other ongoing clinical trials
研究者
相似试验
尚未招募
1 期
Safty Study of TNT for Lower Advanced Rectal CancerRectal cancerJPRN-jRCTs021230062Shinobu Ohnuma35
招募中
2 期
Total neoadjuvant multidrug chemotherapy in the management of gastric cancerIRCT20211211053356N1Shiraz University of Medical Sciences63
尚未招募
1 期
Investigation of the therapeutic effect of electrical stimulation on acute stroke patientsStrokeJPRN-jRCT1032210542Watanabe Yuuki30
招募中
不适用
Total neoadjuvant therapy with short-course radiotherapy versus long-course neoadjuvant chemoradiotherapy in locally advanced rectal cancerNeoplasmsKCT0007169Seoul National University Hospital348
已完成
2 期
Efficacy and Safety study of adjuvant therapy with capecitabine plus oxaliplatin (XELOX) for the Japanese patient with Stage III curative resection Colon cancer -Phase II studyColon cancerJPRN-UMIN000006742Multicenter Study Group of Osaka (MCSGO), Colorectal Cancer Treatment Group195